ERBB2 and breast carcinoma: Breast cancer subtyping, determined by hormone receptor levels such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is crucial for predicting patient survival rates [23].